Zai Lab and argenx have announced receipt of approval from the National Medical Products Administration (NMPA) of China for ...
On Tuesday, Wolfe Research upgraded argenx SE (NASDAQ: ARGX) stock from Peerperform to Outperform with a price target of $697.00. The firm anticipates a positive trajectory for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback